What is next in infusion therapy? Four key trends and innovations catalyzing the industry in 2026

The healthcare landscape is evolving rapidly, driven by tech innovation, gaps in care, and the invaluable perspectives of medical professionals. These changes promise to revolutionize how care is delivered and experienced, bringing both opportunities and challenges to healthcare as a whole and infusion therapy individually.

IV treatment being one of the most wide-spread treatments provided to the 90% of hospitalised patients, yet this field has remained largely traditionalist. 

However, we have entered a new era. Driven by an aging global population and the rise of the "self-aware patient," requirements for mobility, independence, improved patient experience and data-transparency within the treatment workflow have become essential components of the healthcare journey. As the patient moves toward independence, and clinicians seek continual, real-time infusion data, so that they can make more informed and immediate care decisions, the technology must follow.

Additionally, with the growing demand for chronic disease treatments and the ageing baby boomer population, the infusion market is set for significant growth. According to the recent market research, global Infusion Therapy Market size is expected to reach USD 96,390.96 Million by 2034 at a CAGR of 10.6%. This expansion will likely bring forth new technologies and competitors, ultimately enhancing patient outcomes.

Trend 1: Connected IV and the "Interoperability Paradox"

As healthcare systems become more digitally enabled, infusion therapy being one of the fundamental elements of modern healthcare, continues to evolve. Medical devices such as infusion pumps, infusion monitors, or drip counters today are not only perceived as a tool for routine service delivery. Instead, the emergence of connectivity has redefined their value.

The potential benefits of connectivity are immense. Establishing two-way connectivity between devices and Electronic Medical Records (EMRs) allows IV drug prescriptions to be automatically verified, significantly reducing the risk of drug-delivery errors. Furthermore, integrating dose data into the EMR enhances pharmacy efficiency and inventory management. 

However, we are currently witnessing a startling "Connectivity Paradox". While the global infrastructure is vast - with global estimates of connected medical devices reaching up to 3.3 million units - a national survey revealed that only 15% of U.S. hospitals have actually implemented true smart pump interoperability.

When this connectivity is absent, the consequences are significant. Study shows that hospitals with poor interoperability suffer 13% higher 30-day readmission rates for heart failure patients, while the U.S. healthcare system wastes over $30 billion annually due to these inefficiencies. Without automation, the burden falls entirely on the clinician; in urgent scenarios, staff are forced to manually document actions in parallel with treatment, creating a high-pressure environment where human error becomes a major risk. Bridging this gap is no longer just a technical goal for 2026; it is a clinical safety necessity.

Trend 2: Focus on the enhanced safety at at-home infusion care;

Home infusion therapy remains a cost-effective solution by reducing hospital stays and ultimately lowering costs for patients, while also decreasing the risk of hospital-acquired infections. 

The at-home infusion concept has proven both trustworthy and resultful, and a new wave of the industry safety enhancements is emerging as we enter the new year. Governments are expected to implement stricter regulations and adopt new standards for safer and more efficient practices. Only in the US progress is being driven by stronger standards of care through the Infusion Therapy Standards of Practise and the Policies and Procedures for Infusion Nursing along with updated policies from individual care providers. Additionally, new product launches continue to contribute to market growth.

At OSAA Innovation, we are dedicated to prioritizing patient safety through technological advancements in IV therapy specifically designed for the complexities of the home environment. Our solutions, such as iV4Vita, an advanced volumetric infusion pump, are reimagining at-home care by providing enhanced safety throughout the entire data-led infusion treatment process. By empowering clinicians to manage infusion rates and monitor patient safety from a distance, we provide the real-time data necessary for high-quality treatment workflow, bridging the gap between hospital-grade precision and the comfort of the home.

Trend 3: Standardization across infusion devices and workflows;

Infusion devices power care across perioperative, critical care, and pain management, touching approximately 90% of hospitalized patients. Yet a notable share of adverse events is linked to human error in device use. For example, a systematic review of nine studies across various stages of intravenous medication preparation and administration reported errors in 73% of intravenous doses.

Standardizing how we select infusion devices, prime and connect lines, label and document infusions, train staff, and procure equipment can dramatically reduce errors, delays, and variability across departments, introducing a number of strategic advantages, including:

• Mitigating Human Factors: Standardization minimizes the cognitive load on clinicians, reducing the "human factor" mistakes often found in device selection, priming, and documentation.
• Continuity of Care: Utilizing one versatile infusion platform across multiple care areas enables units to shift patients between departments without the dangerous interruptions caused by equipment swaps.
• The Power of a Unified Drug Library: Establishing a single, facility-wide drug library for all pump types ensures consistent concentrations, supports rapid updates, minimizes pharmaceutical waste, and simplifies EMR integration.

Trend 4: Reimagining Patient Experience in infusion therapy

For a patient undergoing a single, acute infusion, the clinical outcome is the primary focus. However, for those managing chronic conditions, the landscape changes entirely. Long-term infusion patients return to the bedside week after week, month after month. Every delayed start, every infusion error, and every hour spent in a sterile, clinical environment becomes a feasible treatment burden and adds a layer of "treatment fatigue", which is an obstacle on the patient's path to recovery.

Over time, the patient experience becomes inseparable from the therapy itself. 

In 2026, we are seeing a shift where "experience" is no longer viewed as a "nice-to-have" benefit, but as an essential part of clinical success. When we prioritize the human experience, we don't just improve satisfaction scores; we empower patients to stay the course on their journey toward long-term health.

As the CEO and Founder of OSAA Innovation, I hope that, through these transformative infusion therapy trends, we will empower patients globally to seize control of their health journeys, addressing existing barriers. Together we build the future of infusion therapy and healthcare, while unlocking its full potential.